Deleted in Liver Cancer 1 (DLC1) Negatively Regulates Rho/ROCK/MLC Pathway in Hepatocellular Carcinoma
2008

DLC1 and Its Role in Liver Cancer Cell Movement

publication 10 minutes Evidence: moderate

Author Information

Author(s): Carmen Chak-Lui Wong, Chun-Ming Ko, Frankie Chi-Fat Chan, Lo-Kong Ching, Yick-Pang Yam, Judy Wai-Ping Ng, Irene Oi-lin Ng

Primary Institution: The University of Hong Kong

Hypothesis

DLC1 suppresses cell motility in hepatocellular carcinoma by negatively regulating the Rho/ROCK signaling pathway.

Conclusion

DLC1 negatively regulates the Rho/ROCK/MLC2 pathway, which helps to suppress metastasis in hepatocellular carcinoma cells.

Supporting Evidence

  • DLC1 was shown to inhibit the formation of stress fibers and focal adhesions in liver cancer cells.
  • Ectopic expression of DLC1 reduced phosphorylation of myosin light chain 2, which is crucial for cell motility.
  • The study demonstrated that ROCK activity is essential for HCC cell migration.

Takeaway

DLC1 is a protein that helps keep liver cancer cells from moving around too much, which is important for stopping cancer from spreading.

Methodology

The study involved overexpressing DLC1 in liver cancer cell lines and assessing its effects on the Rho/ROCK signaling pathway through various assays.

Limitations

The study primarily focused on in vitro experiments, which may not fully replicate in vivo conditions.

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.0001

Digital Object Identifier (DOI)

10.1371/journal.pone.0002779

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication